|
|
|
|
|
|
|
|
|
|
Previous: GENZYME TRANSGENICS CORP, 10-Q, 2000-11-14 |
Next: SUN HEALTHCARE GROUP INC, NT 10-Q, 2000-11-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> OCT-01-2000
<CASH> 35,332
<SECURITIES> 33,673
<RECEIVABLES> 12,622
<ALLOWANCES> 731
<INVENTORY> 667
<CURRENT-ASSETS> 94,817
<PP&E> 54,855
<DEPRECIATION> 18,307
<TOTAL-ASSETS> 161,501
<CURRENT-LIABILITIES> 31,031
<BONDS> 11,782
0
0
<COMMON> 296
<OTHER-SE> 117,595
<TOTAL-LIABILITY-AND-EQUITY> 161,501
<SALES> 62,470
<TOTAL-REVENUES> 62,470
<CGS> 56,670
<TOTAL-COSTS> 74,201
<OTHER-EXPENSES> (2,765)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 1,340
<INCOME-PRETAX> (10,306)
<INCOME-TAX> 180
<INCOME-CONTINUING> (10,486)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (10,560)
<EPS-BASIC> (0.38)
<EPS-DILUTED> (0.38)
</TABLE>
|
|